Institutional investors purchased a net $711.1 thousand shares of NEO during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 75.24% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RUSSELL INVESTMENT MANAGEMENT CO... Bought 344.3 Thousand shares of Neogenomics Inc